Catalyst Wire Dossier Catalyst Wire Dossier

KW-3902IV

· NovaCardia, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KW-3902IV, covering 2008-01-29 to 2008-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment [Phase 2]

See pricing